Literature DB >> 28333203

Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile.

Silvio Danese1,2, Stefanos Bonovas2, Laurent Peyrin-Biroulet3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28333203     DOI： 10.1093/ecco-jcc/jjx025

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  1 in total

1.  Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.

Authors:  Murtaza M Tambuwala; Mohammed N Khan; Paul Thompson; Paul A McCarron
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.